Cuixing Zhou

732 total citations
18 papers, 414 citations indexed

About

Cuixing Zhou is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Cuixing Zhou has authored 18 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in Cuixing Zhou's work include Iron Metabolism and Disorders (7 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Cuixing Zhou is often cited by papers focused on Iron Metabolism and Disorders (7 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Cuixing Zhou collaborates with scholars based in China. Cuixing Zhou's co-authors include Dong Xue, Xiaozhou He, Yimeng Chen, Yun Ji, Yun‐Bo Shi, Xiaozhou He, Liying Miao, Xiaozhou He, Renfang Xu and Zhuojun Zheng and has published in prestigious journals such as BioMed Research International, Cell Death and Disease and Oncotarget.

In The Last Decade

Cuixing Zhou

18 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cuixing Zhou China	10	241	148	86	70	53	18	414
Masakazu Sawanobori Japan	9	97 0.4×	39 0.3×	166 1.9×	17 0.2×	17 0.3×	17	357
Sabine Plasschaert Netherlands	9	181 0.8×	29 0.2×	52 0.6×	40 0.6×	39 0.7×	25	431
Yuqing Miao China	8	70 0.3×	41 0.3×	48 0.6×	18 0.3×	25 0.5×	22	228
Susanne Zieseniss Germany	5	178 0.7×	46 0.3×	217 2.5×	56 0.8×	9 0.2×	5	495
Annegeet G. van den Bos Netherlands	6	154 0.6×	44 0.3×	87 1.0×	106 1.5×	13 0.2×	9	418
Halil Ateş Türkiye	12	114 0.5×	31 0.2×	90 1.0×	41 0.6×	5 0.1×	31	368
Sanne L. N. Brouns Netherlands	13	100 0.4×	24 0.2×	195 2.3×	70 1.0×	15 0.3×	21	413
Ying Siow Tan United States	8	61 0.3×	45 0.3×	69 0.8×	20 0.3×	13 0.2×	10	293
Shan Meng China	10	196 0.8×	40 0.3×	108 1.3×	18 0.3×	9 0.2×	19	366
Ivan D. Tarandovskiy United States	9	101 0.4×	30 0.2×	174 2.0×	54 0.8×	13 0.2×	17	333

Countries citing papers authored by Cuixing Zhou

Since Specialization

Citations

This map shows the geographic impact of Cuixing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuixing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuixing Zhou more than expected).

Fields of papers citing papers by Cuixing Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuixing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuixing Zhou. The network helps show where Cuixing Zhou may publish in the future.

Co-authorship network of co-authors of Cuixing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Cuixing Zhou. A scholar is included among the top collaborators of Cuixing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuixing Zhou. Cuixing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Chen, Yimeng, Yichen He, Zhengsheng Li, et al.. (2024). METTL3 facilitates renal cell carcinoma progression by PLOD2 m6A-methylation under prolonged hypoxia. Cell Death and Disease. 15(1). 62–62. 19 indexed citations

Sun, Yangyang, et al.. (2022). Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy. The Nephron journals/Nephron journals. 146(6). 539–552. 8 indexed citations

Wang, Xiaogang, et al.. (2022). An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System. Frontiers in Genetics. 13. 771344–771344. 5 indexed citations

Liang, Bin, Cuixing Zhou, Hao Lu, et al.. (2021). Upregulation of miR-18a-5p promotes the proliferation of prostate cancer via inhibiting the expression of SLC40A1. Pathology - Research and Practice. 224. 153448–153448. 17 indexed citations

Sun, Yangyang, Cuixing Zhou, Yimeng Chen, et al.. (2021). Quantitative Increase in Short-Chain Fatty Acids, Especially Butyrate Protects Kidney from Ischemia/Reperfusion Injury. Journal of Investigative Medicine. 70(1). 29–35. 24 indexed citations

Zhou, Cuixing, Yimeng Chen, Xiaozhou He, Zhuojun Zheng, & Dong Xue. (2020). <p>Functional Implication of Exosomal miR-217 and miR-23b-3p in the Progression of Prostate Cancer</p>. OncoTargets and Therapy. Volume 13. 11595–11606. 44 indexed citations

Zhou, Cuixing, et al.. (2020). Let‐7c‐5p Is Involved in Chronic Kidney Disease by Targeting TGF‐β Signaling. BioMed Research International. 2020(1). 6960941–6960941. 7 indexed citations

Zhou, Cuixing, Yimeng Chen, Yun Ji, Xiaozhou He, & Dong Xue. (2020). Increased Serum Levels of Hepcidin and Ferritin Are Associated with Severity of COVID-19. Medical Science Monitor. 26. e926178–e926178. 90 indexed citations

Miao, Liying, et al.. (2019). LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14. Journal of Experimental & Clinical Cancer Research. 38(1). 143–143. 48 indexed citations

10.

Chen, Yimeng, Cuixing Zhou, Yangyang Sun, Xiaozhou He, & Dong Xue. (2019). m ⁶ A Rna Modification Modulates Gene Expression and Cancer-Related Pathways in Clear Cell Renal Cell Carcinoma. Epigenomics. 12(2). 87–99. 38 indexed citations

11.

Ding, Tao, Zhuojun Zheng, Renfang Xu, & Cuixing Zhou. (2017). Prognostic factors and outcomes of primary transitional cell carcinoma of the ureter: a population-based study. Oncotarget. 8(39). 65983–65996. 6 indexed citations

12.

Xue, Dong, Cuixing Zhou, Yun‐Bo Shi, Hao Lü, & Xiaozhou He. (2016). Hepcidin as a Biomarker of Impaired Renal Function in Rat Models for Chronic Allograft Nephropathy. Medical Science Monitor. 22. 608–616. 1 indexed citations

13.

Xue, Dong, Cuixing Zhou, Yun‐Bo Shi, et al.. (2016). Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin. Oncotarget. 7(48). 78804–78812. 37 indexed citations

14.

Xue, Dong, Cuixing Zhou, Yun‐Bo Shi, Hao Lü, & Xiaozhou He. (2015). Decreased expression of ferroportin in prostate cancer. Oncology Letters. 10(2). 913–916. 45 indexed citations

15.

Xue, Dong, Cuixing Zhou, Yun‐Bo Shi, Lu Hao, & Xiaozhou He. (2015). MD-miniRNA could be a more accurate biomarker for prostate cancer screening compared with serum prostate-specific antigen level. Tumor Biology. 36(5). 3541–3547. 13 indexed citations

16.

Ding, Tao, Xiaozhou He, Xianlin Xu, et al.. (2014). [Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication].. PubMed. 20(12). 1090–2. 3 indexed citations

17.

Xue, Dong, Xiaozhou He, & Cuixing Zhou. (2014). Serum Hepcidin Level Correlates With Hyperlipidemia Status in Patients Following Allograft Renal Transplantation. Transplantation Proceedings. 46(1). 156–159. 7 indexed citations

18.

Zhou, Cuixing, et al.. (2013). Elevated expression of hepcidin post-renal ischemia reperfusion injury. Acta Biochimica et Biophysica Sinica. 45(4). 342–344. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact